Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Inside ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive T-Cell Malignancies
2+ hour, 53+ min ago (751+ words) Guest Column | July 28, 2026 A conversation between ImvivaBio CMO Jan Davidson-Moncada, MD, Ph.D., and Clinical Leader Executive Editor Abby Proch Allogeneic CAR-T therapies hold promise as off-the-shelf options for patients with aggressive cancers, and ImvivaBio is hoping its CD7-targeting CAR-T candidate…...
Gene Solutions Showcases Global Evidence and Responsible Innovation
3+ hour, 15+ min ago (46+ words) ANTARA News Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026 Unduh Mobile Apps untuk iOS dan Android Copyright © 2026 ANTARA...
South Africa: Study Finds HIV-Specific Immune Activity in Central Nervous System Despite Viral Suppression in Blood
3+ hour, 19+ min ago (1379+ words) Rio de Janeiro, Brazil — For sixteen years, a group of South African adolescents has been part of one of the world's longest-running HIV studies. Born with HIV and treated with antiretroviral therapy from infancy, many have spent their entire lives…...
Scientists develop new CRISPR tool that can program cancer cells to self-destruct
6+ hour, 29+ min ago (658+ words) The Economic Times...
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
3+ hour, 56+ min ago (429+ words) BioSpace Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones – Leadership updates come as Precision advances its lead programs, PBGENE-HBV for chronic hepatitis B and PBGENE-DMD for Duchenne muscular dystrophy…...
Imugene’s allogeneic CAR-T shows early promise in patients Who failed BTKi therapy
10+ hour, 21+ min ago (275+ words) Imugene has reported another encouraging result from the concurrent BTKi cohort of its azer-cel Phase 1b trial, announcing a third response in patients treated with the off‑the‑shelf allogeneic CAR T therapy. The company said the latest responder is a…...
Scientists create "programmable chemotherapy" with CRISPR that recognizes cancer RNA, fragments tumor DNA, and could transform the treatment of difficult mutations.
12+ hour, 43+ min ago (801+ words) An experimental strategy developed by scientists may open a new front in the fight against cancer. The technique uses the enzyme Cas12a2, a component of the CRISPR system, to recognize a specific messenger RNA produced by tumor cells. After identifying the…...
China: Six-Year-Old Girl Subjected to Brain Gene-Editing Therapy Dies After Being Injected with Viruses
14+ hour, 3+ min ago (877+ words) Neuroscientist Qiu Zilong of Shanghai Jiao Tong University is under investigation following the death of a six-year-old girl who was receiving gene-editing therapy during a human trial under his supervision. The child was administered an experimental treatment that involved injecting…...
Transformative embryo research: Who gets to contribute? | PET
18+ hour, 8+ min ago (391+ words) The study, published in Nature, uses base editing (see BioNews 848, 924, 1035 and 1285) to investigate the role of the gene NANOG in the earliest stages of human development. Named after Tír na nÓg, the mythical Celtic 'Land of the Young', NANOG was…...
Base editing in human embryos: Why patient voices matter | PET
18+ hour, 8+ min ago (352+ words) In our recent study published in Nature, my colleagues and I make use of novel genome editing techniques to better understand human embryology (see BioNews 1345 and 1349). There has already been speculation about the future applications of this work, but any…...